(GMAR) First Trust Exchange-Traded - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F4827

GMAR: Flex Options, S&P 500

The FT Cboe Vest U.S. Equity Moderate Buffer ETF - March (GMAR) is an exchange-traded fund that employs a unique investment strategy, utilizing FLexible EXchange Options (FLEX Options) to mirror the performance of the SPDR S&P 500 ETF Trust. By doing so, the fund aims to provide investors with a moderate level of protection against losses while still allowing for potential gains.

The funds non-diversified nature means it can concentrate its investments in a specific type of asset, in this case, FLEX Options referencing the Underlying ETF. This approach allows the fund to closely track the performance of the S&P 500 index while implementing a buffering strategy to mitigate potential losses.

Analyzing the funds recent price movements, we can observe that it has been trending upwards, with its current price of $37.35 exceeding both its 20-day and 50-day simple moving averages (SMA20: $36.69, SMA50: $36.87). The Average True Range (ATR) of 0.57 indicates a relatively low level of volatility, suggesting a stable trading environment. Given the current technical setup, it is likely that the fund will continue to move towards its 52-week high of $38.32.

Considering the funds assets under management (AUM) of $431.49 million, we can infer that it has a reasonable level of investor interest. Combining this with the technical indicators, a forecast for GMAR could be made. If the S&P 500 index continues to perform well, and the fund maintains its current level of volatility, it is possible that GMAR will reach $38.50 by the end of the next quarter, representing a potential gain of around 3.1% from its current price.

To validate this forecast, it is essential to monitor the funds performance in relation to the Underlying ETF and adjust the prediction accordingly. A thorough analysis of the S&P 500 indexs fundamental outlook, including factors such as economic indicators, interest rates, and market sentiment, will be crucial in determining the accuracy of this forecast.

Additional Sources for GMAR ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

GMAR ETF Overview

Market Cap in USD 433m
Category Defined Outcome
TER 0.85%
IPO / Inception 2023-03-17

GMAR ETF Ratings

Growth Rating 55.9
Fundamental -
Dividend Rating 0.0
Rel. Strength -4.44
Analysts -
Fair Price Momentum 36.68 USD
Fair Price DCF -

GMAR Dividends

Currently no dividends paid

GMAR Growth Ratios

Growth Correlation 3m 92.4%
Growth Correlation 12m 72%
Growth Correlation 5y 96.9%
CAGR 5y 12.40%
CAGR/Max DD 5y 1.36
Sharpe Ratio 12m 1.38
Alpha 0.43
Beta 0.491
Volatility 5.37%
Current Volume 20.3k
Average Volume 20d 19.2k
What is the price of GMAR shares?
As of July 01, 2025, the stock is trading at USD 38.95 with a total of 20,324 shares traded.
Over the past week, the price has changed by +0.99%, over one month by +1.92%, over three months by +4.70% and over the past year by +9.62%.
Is First Trust Exchange-Traded a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, First Trust Exchange-Traded (BATS:GMAR) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.92 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GMAR is around 36.68 USD . This means that GMAR is currently overvalued and has a potential downside of -5.83%.
Is GMAR a buy, sell or hold?
First Trust Exchange-Traded has no consensus analysts rating.
What are the forecasts for GMAR share price target?
According to our own proprietary Forecast Model, GMAR First Trust Exchange-Traded will be worth about 41.2 in July 2026. The stock is currently trading at 38.95. This means that the stock has a potential upside of +5.75%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 41.2 5.8%